Print Page   |   Sign In   |   Join!
PSHP News January 2017
Share |

Meet Your Leaders - Dorela Priftanji, PCP SSHP

Dorela Priftanji is a P4 PharmD Candidate at the Philadelphia College of Pharmacy (PCP). Her professional experiences include working as a pharmacy intern at The Johns Hopkins Hospital summer internship program in Baltimore, MD, completing the interprofessional introductory pharmacy practice experiences track at Cooper University Hospital, and currently working as a pharmacy intern at the Magee Rehabilitation Hospital in Philadelphia, PA.

Dorela has been as an executive board member of the PCP Student Society of Health-System Pharmacists since her first undergraduate year in 2012, serving as president during her P2 year in 2014. She has been a member of the Delaware Valley Society of Health System Pharmacists (DVSHP) since 2013 and served as the head PCP student representative of the DVSHP student workgroup in 2015. She has been a member of the American Society of Health-System Pharmacists (ASHP) Pharmacy Student Forum Leadership Development Advisory Group and currently serves as the student representative of the ASHP Commission on Affiliate Relations, which met this year at the ASHP Policy Week to advise the ASHP Board of Directors on methods for strengthening affiliates and building affiliate relationships.

She has been vice president of the Phi Lambda Sigma Pharmacy Leadership Society, member of Rho Chi, mentor in the PCP Student Excellence and Professional Preparation Program, and student representative for the PCP Student Affairs committee. Dorela is passionate about service and research and has offered assistance during community blood drives as an American Red Cross Biomedical Services Volunteer Ambassador as well as provided CPR training to health professional students as an American Heart Association Basic Life Support instructor.

Dorela is currently completing her rotations at the Hospital of the University of Pennsylvania and The Johns Hopkins Hospital.

  • PSHP News: Congratulations New House of Delegates Representatives
  • PSHP News: Call for Speakers for 2017 Annual Assembly
  • PSHP News: Expanded Webinar Programming in 2017
  • Student Submission: Daclizumab
  • Legislative Ledger: PDMP
  • Legislative Ledger: The "Standing Orders" for Pharmacists Has Been Published on; CMS Encourages States to Expand
  • Pharmacists' Scope of Practice
  • Chapter News: MESHP Dinner
  • Tech Corner: PTCB Suspends Implementation of Accredited Education Requirement Originally Planned for 2020
  • ASHP Accepting Applications for Executive Residency
    Postgraduate Training Program Focuses on Leadership and Management
  • New ASHP Certificate Program Offers Advanced Training in Sterile Compounding
Pharmacy News
  • Bipartisan 21st Century Cures Act Becomes Law



PSHP News: Congratulations to new PA House of Delegates Representatives!

Congratulations to Rich Pacitti, Pennsylvania’s newest ASHP House of Delegates representative! Rich will serve a three year term alongside the other elected delegates and alternates. Congratulations as well to Jennifer Belavic and Christine Roussel who will both serve one-year terms as Alternates.

Pennsylvania’s 2017 Delegation is:

  • Rich Pacitti, Delegate
  • Patricia Kienle, Delegate
  • Nishaminy Kasbekar, Delegate
  • Bill O’Hara, Delegate
  • Jill Rebuck, Delegate
  • Jennifer Belavic, Alternate
  • Christine Roussel, Alternate
  • Matt Scola, Alternate

For more information on the House of Delegates, click here

Anna Krupa, PharmD Candidate 2017
Carol Ly, PharmD Candidate 2018
Jennifer Andres, PharmD, BCPS – Faculty Advisor
Temple University School of Pharmacy

Multiple sclerosis (MS) is an unpredictable and potentially disabling disease of the central nervous system. It affects 2.3 million people worldwide and approximately 400,000 people in the US.1 MS is not linked to a specific genetic factor, but rather associated with many other different risk factors including urbanization, smoking, vitamin D deficiency, and excessive sodium intake among others.2-4 MS is an autoimmune disease, in which the body attacks the myelin sheath and oligodendrocytes, by activation of T-helper cells, causing damage to the spine and the brain. There are four types of MS: relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS), primary-progressive MS (PPMS), and progressive-relapsing MS (PRMS). MS is not curable, instead treatment focuses on the protection of myelin sheaths and the suppression of T-cells.Only RRMS can be modified with use of medications including interferon β1a, interferon β1b, or glatiramer acetate.1

The prescription opioid and heroin crisis is the most significant public health crisis facing our state today,” stated Dr. Margaret Jarvis, medical director at Geisinger Marworth Treatment Center. In 2014, 240 million prescriptions for oxycodone, hydrocodone, meperidine, hydromorphone, and propoxyphene were written and 1,700 young adults died from prescription drug overdoses. In 2015 alone, 3,505 people in Pennsylvania died from drug overdose.

ASHP Accepting Applications for Executive Residency
Postgraduate Training Program Focuses on Leadership and Management


ASHP today announced that it is accepting applications for the 2017 ASHP Executive Residency in Association Leadership and Management. Created for pharmacy college graduates who are interested in a career in association management, the paid 12-month residency program provides one resident with hands-on training under the guidance of ASHP executives in all facets of not-for-profit association leadership and management.

The ASHP Executive Residency was created in 1968. Since its creation, graduates of the program have gone on to serve in leadership roles in associations, government, for-profit corporations, academia, philanthropy, and various other sectors.
New ASHP Certificate Program Offers Advanced Training in Sterile Compounding - Online Continuing Education Readies Pharmacy Personnel to Oversee Compounding Activities


ASHP recently released the latest offering from its Professional Certificate line, the Advanced Sterile Product Preparation Training and Certificate Program. The online continuing education program was developed for pharmacists and pharmacy technicians who manage personnel and facilities involved in compounding sterile preparations.

Available for individual and institutional purchase, the Advanced Sterile Product Preparation Training and Certificate Program features nine modules that emphasize the many considerations required when developing competent personnel and designing appropriate environments and facilities for compliant sterile product preparation. The curriculum covers the elements of essential cleanroom design, standards for selecting ingredients and other products used in sterile product preparation, and regulatory and quality control guidance, including the Drug Quality and Security Act as well as USP Chapter <797>. The course also explores creating a culture that supports safe and compliant sterile preparation, USP Chapter <800> guidelines and procedures for handling hazardous drugs, and the challenges associated with managing outsourced compounding providers or compounding activities in a multisite system.
Continue reading.

web link | return to headlines

Pharmacy News

Bipartisan 21st Century Cures Act Becomes Law
[January 15, 2017, AJHP News]

Cheryl A. Thompson

BETHESDA, MD 22 Dec 2016—The 21st Century Cures Act—conceived as a means to change the way the United States treats disease—was signed into law by President Barack Obama on December 13, 2016.

"We're tackling cancer, brain disease, substance abuse disorders, and more," the president proclaimed during the signing ceremony at the White House. "And none of this work would have been possible without bipartisan cooperation in both houses of Congress."

With at least 88% of legislators in each major political party in the House of Representatives and the Senate voting in favor of the 21st Century Cures Act, it passed with overwhelming majorities.

Continue reading.

web link | return to headlines

Part D Data Underscore Lack of Medication Management Superstars
[January 15, 2017, AJHP News]

Kate Traynor

BETHESDA, MD 21 Dec 2016—The Centers for Medicare and Medicaid Services (CMS) in October awarded five stars for overall quality—the highest rating possible—to six high-performing Medicare Part D prescription drug plan sponsors.

The star ratings are based on performance data from 2015 and, for the first time, take into account whether Medicare enrollees receive a complete medication review (CMR) as a component of their Part D plan's medication therapy management (MTM) services.

CMRs may be conducted by a pharmacist or other healthcare provider and must include a written summary of the evaluation and an action plan to improve the patient's medication use.

But the CMR measure has little apparent effect on the drug plan sponsor's overall star rating.

Continue reading.

web link | return to headlines

Rucaparib Approved as Targeted Monotherapy for Advanced Ovarian Cancer

Kate Traynor

BETHESDA, MD 20 Dec 2016— FDA and Clovis Oncology on December 19 announced the approval of rucaparib oral tablets as monotherapy for advanced ovarian cancer, characterized by specific deleterious BRCA mutations, in women previously treated with two or more chemotherapy regimens.

Women whose tumors may respond to rucaparib therapy are identified using the FoundationFocus CDxBRCA sequencing test, which has been approved by FDA for selection of patients for rupcaparib treatment.

Rucaparib is available now under the brand name Rubraca, according to the company.

The labeling (PDF) for rucaparib describes the therapy as an inhibitor of poly ADP-ribose polymerases, a family of enzymes involved in DNA repair.

Continue reading.

web link | return to headlines



PSHP Board of Directors
President, William O’Hara, PharmD, BCPS, BCOP

President-elect, Jill Rebuck, PharmD, BCPS, FCCM, FCCP

Immediate Past President, Matt Scola, PharmD, MHA

Treasurer, David Cecere, MBA,PharmD

Secretary, Jennifer Cimoch, PharmD, MS

Board Member, Larry Carey, PharmD

Board Member, Brad Cooper, PharmD, FCCM

Board Member, Thao Huyhn, PharmD, BCOP

Board Member, Sejal Patel, PharmD, BCPS

About PSHP
The mission of PSHP is to advance and support the professional practice of health-system pharmacy and serve as its collective voice through education, networking and advocacy.

Pennsylvania Society of Health-System Pharmacists
PO Box 9874
Erie, PA 16505

e-mail link

American Society of Health System Pharmacy
ASHP is a 35,000-member national professional association that represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care, and other components of health care systems. ASHP is the only national organization of hospital and health-system pharmacists and has a long history of improving medication use and enhancing patient safety.

American Society of Health-System Pharmacists
7272 Wisconsin Avenue
Bethesda, MD 20814

e-mail link
web link













This message was sent to @@email@@ from the Pennsylvania Society of Health-System Pharmacists. If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@
Membership Management Software Powered by YourMembership  ::  Legal